pargyline has been researched along with Botulism in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Botulism: A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simpson, LL | 1 |
1 other study available for pargyline and Botulism
| Article | Year |
|---|---|
The interaction between 5-hydroxytryptamine and botulinum toxin type A.
Topics: 5-Hydroxytryptophan; Acetylcholine; Animals; Antitoxins; Botulism; Chlorine; Clostridium botulinum; | 1968 |